Surefire snags $16.4M; Cigna stands firm on Dx mandate;

@FierceMedDev: At AdvaMed, European regulations are on many CEOs' minds. Editor's corner | Follow @FierceMedDev

@MarkHFierce: The debt ceiling/budget fight has given an opening to device tax opponents. They hope for a repeal before year-end. More | Follow @MarkHFierce

@MichaelGFierce: Alnylam heralds positive results for RNAi amyloidosis drug. Story | Follow @MichaelGFierce

> Colorado's Surefire Medical has raised $16.4 million to market catheters designed to deliver cancer treatments. Article

> A Cigna executive said the insurer will expand a new policy requiring genetic counseling before it will cover certain diagnostic tests. Story

> Fresh off its FDA approval, NeoTract has treated its first patient with the UroLift device for enlarged prostates. News

> Luminex ($LMNX) won FDA clearance and a CE mark for its xTAG CYP2C19 diagnostic kit. Release

> In a new study, Respicardia's implantable sleep apnea device decreased patients' apnea-hypopnea index by more than 50% and improved oxygenation at about the same rate. More

> Medtronic ($MDT) has forked over $290,000 to settle a lawsuit claiming it paid Hispanic employees less than their white colleagues. Item

Biotech News

@FierceBiotech: The 2013 Fierce 15 biotech execs take a bow. Editor's corner | Follow @FierceBiotech

@JohnCFierce: Some folks might want to adjust their timelines on ARN-509. PhIII is coming. Item | Follow @JohnCFierce

@DamianFierce: Thanks to everyone cheering my trip to FierceBiotech! | Follow @DamianFierce

> SEC charges another biotech profiteer linked to insider trading scheme. More

> Ex-InterMune CEO's press-release pomp could leave legal legacy. Story

> AbbVie continues deal spree with $405M CF tie-up with Galapagos. News

Pharma News

@FiercePharma: Top story on our website this A.M.: Who are the richest biopharma execs? Not all the usual suspects. Article | Follow @FiercePharma

> GlaxoSmithKline's China sales set for 30% hit, analysts figure. More

> Servier offers $483M to buy out other Egis shareholders. Story

> Pfizer rolls out digital reps in U.K., hoping for access to primary-care docs. Article

Pharma Manufacturing News

@EricPFierce: After sales of Bydureon came up short, Bristol-Myers, AstraZeneca report manufacturing has too. Article | Follow @EricPFierce

> FDA warns Agila plant over torn gloves. Story

> Pharma squares off against compounders in lobbying fight. News

> J&J wins a bright spot after string of recalls. More

> FDA beefs up Indian staff in face of serious problems. Story

> U.K., Australia gather FDA intel on Ranbaxy ban. Report

Biotech Research News

@EmilyMFierce: $3.7M NIH program to fund biomedical research training. Item | Follow @EmilyMFierce

> Stem cell therapy protects vision in preclinical retinal disease study. More

> Pre-leukemia drug shows brain tumor regression in mice. News

> Stem cell reprogramming made easier by removing one protein. Report

> New compound kills tuberculosis bacterium in lab tests. Story

> NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.